Shingles vaccine may lower dementia risk: Study
A major study from the US found that getting the shingles vaccine—especially the newer Shingrix shot—may cut your risk of developing dementia by about 18% over five years.
Shingrix outperformed the older Zostavax, with people who got it seeing an 18% lower dementia risk than those who got Zostavax.
The benefit held up across all age groups, even after accounting for hundreds of potential confounding factors.
Researchers think shingles vaccines might help by reducing inflammation
Dementia is a huge concern as people get older, so anything that helps prevent it is big news—even if you're not thinking about it yet.
Researchers think shingles vaccines might help by reducing inflammation and stopping harmful viral flare-ups in the body.
This study adds to growing evidence that vaccines can protect more than just against infections—they could help keep your brain healthier in the long run.